Cytogenetic effects on lymphocytes in osteoporotic patients on long- term fluoride therapy

Pharmacy World and Science

Volumn 20, Issue 5, 1998, Pages 214-218

  Van Asten, Paul ^a   Darroudi, Firouz ^b,c   Natarajan, Adaqapalam T ^b,c   Terpstra, Ido J ^d   Duursma, Symen A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c JA Cohen Institute Interuniversity Research Institute for Radiopathology and Radiation Protection   (Netherlands)

^d ASTELLAS PHARMA INC   (Japan)

Author keywords

Cytogenetic effects; Disodium monofluorophosphate; Genetoxicity; Lymphocytes; Osteoporosis; Patient study; Sodium fluoride

Indexed keywords

CALCIUM; FLUORIDE SODIUM; VITAMIN D;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOPATHOGENIC EFFECT; DRUG EFFECT; DRUG FORMULATION; FEMALE; GENOTOXICITY; HUMAN; LONG TERM CARE; LYMPHOCYTE; OSTEOPOROSIS;

ADULT; AGED; CELL CYCLE; CHROMOSOME ABERRATIONS; DOUBLE-BLIND METHOD; FEMALE; FLUORIDES; HUMANS; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MIDDLE AGED; OSTEOPOROSIS;

EID: 0031774311     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008672220053     Document Type: Article

References (19)

1. Philips S, Fox N, Jacobs J, Wright WE. The direct medical costs of osteoporosis for American women aged 45 and older. Bone 1988;9: 271-9.
2. Dempster W, Lindsay R. Pathogenesis of osteoporosis. Lancet 1993;341: 797-801.
3. Duursma SA, Raymakers JA, Scheven BAA, Jansen PAF. Osteoporosis reviews in clinical gerontology 1993;3: 135-46.
4. Riggs BL Fluoride revisited. Research and Clinical Forums 1993;15(1): 36-9.
5. Li Y, Dunipace AJ, Stooky GK. Genotoxic effects of fluoride: a controversial issue. Mutat Res 1988;195: 127-36.
6. Baylink DJ. Serum fluoride levels. In Primer on metabolic bone diseases and disorders of mineral metabolism. 1st ed. 170-1. Kelseyville, CA: American Society for Bone and Mineral Research, California, 1990.
7. Albanese R. Sodium fluoride and chromosome damage (in vitro human lymphocytes and in vivo micronucleus assays). Mutagenesis 1987;6: 497-9.
8. Kishi K, Tonomura A. Cytogenetic effects of sodium fluoride. Mutat Res 1984;130: 367(abstract).
9. Scott D, Roberts SA. Extrapolation from in vitro tests to human risk. Experience with sodium fluoride clastogenicity. Mutat Res 1987;189: 47-58.
10. Kaminsky LS, Mahoney MC, Leach J, Melius J, Miller MJ. Fluoride: benefits and risks of exposure. Crit Rev Oral Biol Med 1990;1(4): 268-81.
11. Zeiger E, Shelby MD, Witt KI. Genetic toxicity of fluoride. Environ Mol Mutagen 1993;21(4): 309-18.
12. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature (London) 1974;251: 156-68.
13. Glerum JH, van Dijk A, Klein SW. A new and improved gas Chromatographic method for the determination of fluoride in plasma and feaces. Pharm Weekbl [Sci] 1984;6: 75-9.
14. Smith GE. Is fluoride a mutagen? Sci Tot Environ 1988;68: 79-96.
15. Thomson EJ, Kolanowski FM, Perry PE. The effect of fluoride on chromosome aberration and sister-chromatid exchange frequencies in cultured human lymphocytes. Mutation Res 1985;144: 89-92.
16. Carrano AV, Natarajan AT. Considerations for population monitoring using cytogenic techniques. ICPEMC Publication no14. Mutat Res 1988;204: 379-407.
17. Evans HJ, O'Riordan ML. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat Res 1975;31: 135-48.
18. Rich C, Feist E. The actions of fluoride on bone. In Vischer TL, ed. Fluoride in medicine. Bern: Huber, 1970: 70-87.
19. Duffery PH, Tratbar HC, Jarkowski TL. Giant cells in bone marrow of patients on high dose fluoride treatment. Ann Intern Med 1971;76: 745-7.